Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Bringing COVID-19 home for Christmas: a need for enhanced testing in healthcare institutions after the holidays

View ORCID ProfileDavid R. M. Smith, Audrey Duval, Jean Ralph Zahar, Lulla Opatowski, Laura Temime on behalf of the EMEA-MESuRS working group on nosocomial SARS-CoV-2 modelling
doi: https://doi.org/10.1101/2020.12.18.20248460
David R. M. Smith
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David R. M. Smith
  • For correspondence: david.smith@pasteur.fr
Audrey Duval
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Ralph Zahar
4IAME, UMR 1137, Université Paris 13, Sorbonne Paris Cité, France; Service de Microbiologie Clinique et Unité de Contrôle et de Prévention du Risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, Bobigny, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lulla Opatowski
1Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), Paris, France
2Université Paris-Saclay, UVSQ, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France
3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Temime
3Modélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France
5PACRI unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Festive gatherings this 2020 holiday season threaten to cause a surge in new cases of novel coronavirus disease 2019 (COVID-19). Hospitals and long-term care facilities are key hotspots for COVID-19 outbreaks, and may be at elevated risk as patients and staff return from holiday celebrations in the community. Some settings and institutions have proposed fortified post-holiday testing regimes to mitigate this risk. We use an existing model to assess whether implementing a single round of post-holiday screening is sufficient to detect and manage holiday-associated spikes in COVID-19 introductions to the long-term care setting. We show that while testing early helps to detect cases prior to potential onward transmission, it likely to miss a substantial share of introductions owing to false negative test results, which are more probable early in infection. We propose a two-stage post-holiday testing regime as a means to maximize case detection and mitigate the risk of nosocomial COVID-19 outbreaks into the start of the new year. Whether all patients and staff should be screened, or only community-exposed patients, depends on available testing capacity: the former will be more effective, but also more resource-intensive.

Competing Interest Statement

LO reports grants from Pfizer, outside the submitted work. All other authors report no competing interests.

Funding Statement

The work was supported by the French National Research Agency (ANR) project MOD-COV (ANR-20-COVI-0071). DS is supported by a Canadian Institutes of Health Research Doctoral Foreign Study Award (Funding Reference Number 164263) as well as the ANR project SPHINX-17-CE36-0008-01.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study used inter-individual contact data from the i-Bird study, which obtained all authorizations in accordance with French regulations regarding medical research and information processing. All French IRB-equivalent agencies accorded the i-Bird program official approval (CPP 08061; Afssaps 2008-A01284-51; CCTIRS 08.533; CNIL AT/YPA/SV/SN/GDP/AR091118 N 909036). Signed consent by patients and staff was not required according to the French Ethics Committee to which the project was submitted.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Simulated data is available from authors upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted December 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Bringing COVID-19 home for Christmas: a need for enhanced testing in healthcare institutions after the holidays
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Bringing COVID-19 home for Christmas: a need for enhanced testing in healthcare institutions after the holidays
David R. M. Smith, Audrey Duval, Jean Ralph Zahar, Lulla Opatowski, Laura Temime
medRxiv 2020.12.18.20248460; doi: https://doi.org/10.1101/2020.12.18.20248460
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Bringing COVID-19 home for Christmas: a need for enhanced testing in healthcare institutions after the holidays
David R. M. Smith, Audrey Duval, Jean Ralph Zahar, Lulla Opatowski, Laura Temime
medRxiv 2020.12.18.20248460; doi: https://doi.org/10.1101/2020.12.18.20248460

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1943)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
  • Epidemiology (11097)
  • Forensic Medicine (8)
  • Gastroenterology (622)
  • Genetic and Genomic Medicine (3164)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2041)
  • Health Policy (862)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12713)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2981)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1549)
  • Ophthalmology (476)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2781)
  • Public and Global Health (5588)
  • Radiology and Imaging (1091)
  • Rehabilitation Medicine and Physical Therapy (631)
  • Respiratory Medicine (759)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)